KIM PETER S
SEC insider (Form 3/4/5 filer). CIK 0001181180. Director at Entrada Therapeutics, Inc. (TRDA). 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 10, 2026. Located in BOSTON, MA.
Companies KIM PETER S has filed insider reports for
- Entrada Therapeutics, Inc. (TRDA): Director
KIM PETER S
CIK: 0001181180
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TRDA
Entrada Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 10, 2026TRDA
Entrada Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
19K shares- - Jun 11, 2025TRDA
Entrada Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
19K shares- - May 14, 2024TRDA
Entrada Therapeutics, Inc.
PurchaseDirect25K shares at avg. $14.59$365K - May 13, 2024TRDA
Entrada Therapeutics, Inc.
PurchaseDirect25K shares at avg. $14.68$367K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | TRDA Entrada Therapeutics, Inc. | Award Stock Option (Right to Buy) | 19,000 | - | - | Direct |
| Jun 11, 2025 | TRDA Entrada Therapeutics, Inc. | Award Stock Option (Right to Buy) | 19,000 | - | - | Direct |
| May 14, 2024 | TRDA Entrada Therapeutics, Inc. | Purchase | 25,000 | $14.59 | $364,673 | Direct |
| May 13, 2024 | TRDA Entrada Therapeutics, Inc. | Purchase | 25,000 | $14.68 | $367,010 | Direct |
1-4 of 4 transactions